Neurology News

Private equity has had a long involvement with and continues to stay active in the business of health care.

Eterna Therapeutics Inc. announced it has entered into an exclusive option and license agreement with Lineage Cell Therapeutics Inc. to create novel induced hypoimmune pluripotent stem cell lines for use in cell transplant therapies.

The Veterans’ Health Administration will provide coverage of a drug for the treatment of Alzheimer’s disease to veterans with early stages of the disease, according to a press release from the drug’s manufacturer.

With the increasing number of available treatments for Alzheimer’s disease, it is important for patients with cognitive concerns to openly communicate with their doctors, the Alzheimer’s Association said in a press release.

Results of a randomized, double-blind trial showed that hyperbaric oxygen therapy improved cognitive and behavioral function in children experiencing persistent post-concussion syndrome, as published in Scientific Reports.

The FDA approved dabrafenib with trametinib for children with previously untreated low-grade glioma who harbor BRAF V600E mutations and require systemic therapy.

Horizon Therapeutics recently announced new MRI imaging data from a phase 3 clinical trial, which demonstrated that Uplizna reduced formation of asymptomatic optic nerve lesions in patients with neuromyelitis optica spectrum disorder.

Treatment with zavegepant 10 mg nasal spray was safe, well-tolerated and provided pain and symptom relief for moderate to severe migraine compared with placebo, according to a study published in The Lancet Neurology.

Men aged 65 years and older had a significantly higher rate of skull fracture compared with women after blunt head trauma, mostly because of falls, according to a study from The American Journal of Emergency Medicine.

The emergence of visual artistic creativity among those with frontotemporal dementia may be linked to early lesion-induced activation of the visual cortex and may depend on environment or genetics, according to research presented in JAMA Neurology.